←Back to Expert Scholars
Translational Medicine / 转化医学Checkpoint Combinations, Novel Immunotherapy
Hussein Tawbi
MD, PhD
🏢MD Anderson Cancer Center🌐USA
Professor and Deputy Chair, Melanoma Medical Oncology
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Hussein Tawbi leads melanoma immunotherapy trials at MD Anderson and was principal investigator of RELATIVITY-047 establishing nivolumab plus relatlimab. He has pioneered checkpoint combinations for brain metastases. His work has expanded novel LAG-3 and dual checkpoint strategies.
Share:
🧪Research Fields 研究领域
melanoma immunotherapy
nivolumab plus relatlimab
LAG-3 combinations
brain metastases immunotherapy
RELATIVITY-047
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Hussein Tawbi 的研究动态
Follow Hussein Tawbi's research updates
留下邮箱，当我们发布与 Hussein Tawbi（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment